128 related articles for article (PubMed ID: 22641442)
1. Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India.
Kumar P; Kane S; Rathod GP
Braz Oral Res; 2012; 26(3):228-34. PubMed ID: 22641442
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
[TBL] [Abstract][Full Text] [Related]
4. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
5. Expression of the tumour suppressor gene p53 in oral cancer.
Langdon JD; Partridge M
Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India.
Kaur J; Srivastava A; Ralhan R
Int J Cancer; 1994 Aug; 58(3):340-5. PubMed ID: 8050814
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
10. p53 and Ki 67 expression in preneoplastic and neoplastic lesions of the oral mucosa.
Girod SC; Krueger G; Pape HD
Int J Oral Maxillofac Surg; 1993 Oct; 22(5):285-8. PubMed ID: 8245568
[TBL] [Abstract][Full Text] [Related]
11. Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.
Ioffe OB; Papadimitriou JC; Drachenberg CB
Hum Pathol; 1998 Oct; 29(10):1150-9. PubMed ID: 9781657
[TBL] [Abstract][Full Text] [Related]
12. [Progression of leukoplakia is associated with changes in apoptotic and mitotic index as well as in p53 and Ki-67 expression].
Kövesi G; Szende B
Magy Onkol; 2002; 46(4):333-8. PubMed ID: 12563356
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
Pich A; Margaria E; Chiusa L
J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
[TBL] [Abstract][Full Text] [Related]
15. The significance of PCNA and p53 protein in some oral tumors.
Tsuji T; Mimura Y; Wen S; Li X; Kanekawa A; Sasaki K; Shinozaki F
Int J Oral Maxillofac Surg; 1995 Jun; 24(3):221-5. PubMed ID: 7594756
[TBL] [Abstract][Full Text] [Related]
16. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias.
Bortoluzzi MC; Yurgel LS; Dekker NP; Jordan RC; Regezi JA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Dec; 98(6):698-704. PubMed ID: 15583543
[TBL] [Abstract][Full Text] [Related]
17. Actual proliferating index in oral squamous cell carcinoma and leukoplakia.
Chandak AR; Gadbail AR; Chaudhary MS; Chandak SA; Wadhwani R
J Investig Clin Dent; 2011 Aug; 2(3):176-83. PubMed ID: 25426788
[TBL] [Abstract][Full Text] [Related]
18. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
[TBL] [Abstract][Full Text] [Related]
19. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
20. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
